Key result
MOLLI 5-3-3 yields ~61 ms higher native myocardial T1 values than the 4-1-3-1-2 scheme.
Why the study?
The study was conducted to systematically compare two MOLLI T1 mapping sequences and their impact on native myocardial T1, post-contrast T1, and extracellular volume.
Does the T1 mapping MOLLI 5(3)3 acquisition scheme provide more accurate estimation of native and post-contrast myocardial T1 values and extracellular volume compared to the MOLLI 4(1)3(1)2 scheme in patients undergoing 1.5 T cardiac magnetic resonance for cardiomyopathy work-up?
Cohort (n=163)
No
Does the T1 mapping MOLLI 5(3)3 acquisition scheme provide more accurate estimation of native and post-contrast myocardial T1 values and extracellular volume compared to the MOLLI 4(1)3(1)2 scheme in patients undergoing 1.5 T cardiac magnetic resonance for cardiomyopathy work-up?
The MOLLI 5(3)3 acquisition scheme reliably estimates both native (long) and post-contrast (short) myocardial T1 values at 1.5 T CMR, eliminating the need to switch to a 4(1)3(1)2 scheme post-contrast and avoiding the systematic underestimation of native T1 seen with 4(1)3(1)2.
Answers are grounded in this paper and cite their sources.
Supports preferring MOLLI 5(3)3 to avoid native T1 underestimation at 1.5 T; extends in vitro comparisons to cardiomyopathy patients.
Objectives: To systematically compare two modified Look-Locker inversion recovery (MOLLI) T1 mapping sequences and their impact on (1) myocardial T1 values native, (2) post-contrast and (3) extracellular volume (ECV). Methods: 200 patients were prospectively included for 1.5 T CMR for work-up of ischemic or non-ischemic cardiomyopathies. To determine native and post-contrast T1 for ECV calculation, two different T1 mapping MOLLI acquisition schemes, 5(3)3 (designed for native scans with long T1) and 4(1)3(1)2 (designed for post-contrast scans with short T1), were acquired in identical mid-ventricular short-axis slices. Both schemes were acquired in native and post-contrast scans. Results: Datasets from 163 patients were evaluated (age 55 ± 17 years; 38% female). Myocardial T1 native for 5(3)3 was 1017 ± 42 ms vs. 956 ± 40 ms for 4(1)3(1)2, with mean intraindividual difference −61 ms (p < 0.0001). Post-contrast myocardial T1 in patients was similar for both acquisition schemes, with 494 ± 48 ms for 5(3)3 and 490 ± 45 ms for 4(1)3(1)2 and mean intraindividual difference −4 ms. Myocardial ECV for 5(3)3 was 27.6 ± 4% vs. 27 ± 4% for 4(1)3(1)2, with mean difference −0.6 percentage points (p < 0.0001). Conclusions: The T1 MOLLI 5(3)3 acquisition scheme provides a reliable estimation of myocardial T1 for the clinically relevant range of long and short T1 values native and post-contrast. In contrast, the T1 MOLLI 4(1)3(1)2 acquisition scheme may only be used for post-contrast scans according to its designed purpose.
No takes yet. Share an insight, caveat, or question.
Krumm et al. (2022) conducted a cohort in Ischemic or non-ischemic cardiomyopathy work-up (including myocarditis/pericarditis) (n=163). T1 mapping MOLLI 5(3)3 acquisition scheme vs. T1 mapping MOLLI 4(1)3(1)2 acquisition scheme was evaluated on Native myocardial T1 value (ms) (MD -61 ms, p=<0.0001). The T1 mapping MOLLI 5(3)3 scheme yielded higher native myocardial T1 values than the 4(1)3(1)2 scheme, avoiding systematic underestimation.
Synapse has enriched 10 related papers. Consider them for comparative context: